Patent details

Basic Information

Publication number:

EP3518924

PCT Application Number:

US2017054288

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP178574950

PCT Publication Number:

WO2018064472

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SOLID DISPERSION FORMS OF RIFAXIMIN

French Title of Invention:

FORMES DE DISPERSIONS SOLIDES DE RIFAXIMINE

German Title of Invention:

FESTE DISPERSIONSFORMEN VON RIFAXIMIN

SPC Number:

Dates

Filing date:

29/09/2017

Grant date:

10/08/2022

EP Publication Date:

07/08/2019

PCT Publication Date:

05/04/2018

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/08/2022

EP B1 Publication Date:

10/08/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

29/09/2022

Expiration date:

29/09/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/08/2022

 

 

Name:

Salix Pharmaceuticals, Inc.

Address:

400 Somerset Corporate Boulevard, Bridgewater, NJ 08807, United States (US)

Inventor

1

Name:

KABIR, Mohammed A.

Address:

United States (US)

2

Name:

GOLDEN, Pam

Address:

United States (US)

Priority

Priority Number:

201662402119 P

Priority Date:

30/09/2016

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/437; A61K 9/28; A61K 9/20;

Publication

European Patent Bulletin

1

Issue number:

202232

Publication date:

10/08/2022

Description:

Grant (B1)

2

Issue number:

202237

Publication date:

14/09/2022

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages